BCAX
Price
$28.15
Change
-$0.76 (-2.63%)
Updated
Jul 13 closing price
Capitalization
1.85B
35 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$28.07
Change
-$0.85 (-2.94%)
Updated
Jul 13 closing price
Capitalization
3.53B
29 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs RCUS

BCAX vs RCUS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BCAX vs. RCUS commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a StrongBuy and RCUS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (BCAX: $28.15 vs. RCUS: $28.07)
Brand notoriety: BCAX and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 34% vs. RCUS: 73%
Market capitalization -- BCAX: $1.85B vs. RCUS: $3.53B
BCAX [@Biotechnology] is valued at $1.85B. RCUS’s [@Biotechnology] market capitalization is $3.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, BCAX is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 6 TA indicator(s) are bullish while RCUS’s TA Score has 4 bullish TA indicator(s).

  • BCAX’s TA Score: 6 bullish, 4 bearish.
  • RCUS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BCAX is a better buy in the short-term than RCUS.

Price Growth

BCAX (@Biotechnology) experienced а -3.66% price change this week, while RCUS (@Biotechnology) price change was -6.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

BCAX is expected to report earnings on Aug 18, 2026.

RCUS is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($3.53B) has a higher market cap than BCAX($1.85B). BCAX YTD gains are higher at: 67.261 vs. RCUS (17.793). BCAX has higher annual earnings (EBITDA): -173.93M vs. RCUS (-350M). RCUS has more cash in the bank: 822M vs. BCAX (540M). BCAX has less debt than RCUS: BCAX (1.44M) vs RCUS (113M). RCUS has higher revenues than BCAX: RCUS (236M) vs BCAX (0).
BCAXRCUSBCAX / RCUS
Capitalization1.85B3.53B52%
EBITDA-173.93M-350M50%
Gain YTD67.26117.793378%
P/E Ratio3.41N/A-
Revenue0236M-
Total Cash540M822M66%
Total Debt1.44M113M1%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCAXRCUS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
USML44.40N/A
N/A
ETRACS 2x Lvrgd MSCI US Mn Vl Fct TR ETN
MST8.09N/A
N/A
Defiance Leveraged Long + Inc MSTR ETF
TDVG49.43-0.09
-0.18%
T. Rowe Price Dividend Growth ETF
UFEB38.78-0.11
-0.27%
Innovator US Equity Ultra Bffr ETF™ Feb
GSUI10.44-0.27
-2.57%
Grayscale Sui Staking ETF

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with CLDX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
-2.63%
CLDX - BCAX
48%
Loosely correlated
-1.48%
PCVX - BCAX
47%
Loosely correlated
-2.03%
BCYC - BCAX
45%
Loosely correlated
-1.36%
NRIX - BCAX
45%
Loosely correlated
-1.52%
RCUS - BCAX
44%
Loosely correlated
-2.94%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-2.94%
XNCR - RCUS
52%
Loosely correlated
-5.62%
VIR - RCUS
50%
Loosely correlated
-2.41%
DYN - RCUS
46%
Loosely correlated
+0.94%
NRIX - RCUS
45%
Loosely correlated
-1.52%
AURA - RCUS
44%
Loosely correlated
+2.34%
More